Logo (Midazolam 01)
Midazolam Injection, Solution
Product Images NDC 0409-0001
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Midazolam (NDC 0409-0001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Midazolam 01a)
Chemical structure of midazolam hydrochloride, showing its molecular framework with a chlorine atom, fluorine atom, and the hydrochloride component (HCl). The diagram includes heterocyclic rings characteristic of this active ingredient.*
Chemical Structure (Midazolam 02)
Chemical structure diagram showing Midazolam and its open-ring form, illustrating the structural change between the two molecular forms of Midazolam.*
Chart (Midazolam 03)
A line graph titled 'pH Dependence of Open-ring Form in Water' showing the percentage of open-ring form on the y-axis (ranging from 0 to 60%) versus pH on the x-axis (ranging from 2.5 to 5.5). The graph illustrates a decreasing trend in the open-ring form percentage as pH increases.*
Logo (Midazolam 04)
Principal Display Panel (2 mL Vial Label RL-7447)
Label of Midazolam Injection, USP 2 mg per 2 mL (1 mg/mL) single-dose vial. The label indicates preservative-free solution for intravenous or intramuscular use. It includes dosage strength, usage instructions, and distributor Hospira, Inc., Lake Forest, IL. The vial size is 2 mL.*
Principal Display Panel (2 mL Vial Box CA-7201)
Midazolam Injection USP 2 mg per 2 mL (1 mg/mL) single-dose flitop vial carton label by Hospira, Inc. The label states the product is preservative-free, for intravenous or intramuscular use, with 25 vials of 2 mL each. It includes storage instructions and manufacturer details with barcode and NDC 0409-2305-17.*
Principal Display Panel (5 mL Vial Label RL-7448)
Label for Midazolam Injection, USP 5 mg per 5 mL (1 mg/mL) single-dose vial. The preservative-free solution is for intravenous or intramuscular use. The label includes NDC 0409-2305-04 and is distributed by Hospira, Inc., Lake Forest, IL. It is marked Rx only and indicates discard of unused portion.*
Principal Display Panel (5 mL Vial Box CA7202)
Midazolam Injection, USP 5 mg/5 mL (1 mg/mL) single-dose Fliptrop vial carton label by Hospira, Inc. The label indicates the product is preservative-free and intended for intravenous or intramuscular use. Packaging size is 10 vials of 5 mL each. Includes storage instructions and NDC codes 0409-2305-05 and 0409-2305-04.*
Principal Display Panel (1 mL Vial Label RL-7449)
Midazolam Injection, USP 5 mg/mL single-dose vial label. The vial contains 1 mL solution, preservative-free, indicated for intravenous or intramuscular use. The label shows the Hospira, Inc. distributor information and includes NDC 0409-2308-21 with batch and expiration code areas.*
Principal Display Panel (1 mL Vial Box CA7205)
Midazolam Injection, USP 5 mg/mL preservative-free solution in a 10 x 1 mL single-dose fliptop vial carton. Labeled for intravenous or intramuscular use, distributed by Hospira, Inc. The label includes storage instructions and a barcode, specifying the product contains midazolam hydrochloride equivalent to 5 mg per mL.*
Principal Display Panel (2 mL Vial Label RL-7450)
Label for Midazolam Injection, USP 5 mg/mL in a 2 mL single-dose vial containing 10 mg per vial. It is preservative-free, for intravenous or intramuscular use, prescription only, and distributed by Hospira, Inc., Lake Forest, IL. The label includes an Rx-only symbol and a lot number/barcode area.*
Principal Display Panel (2 mL Vial Box CA7206)
Box packaging label for Midazolam Injection, USP 10 mg/2 mL (5 mg/mL) preservative-free solution for injection. The product contains 10 single-dose fliptop vials of 2 mL each, indicated for intravenous or intramuscular use. Labeled by Hospira, Inc., the packaging includes dosage form, route, NDC, and storage instructions.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
